Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (61-70 of 279) with videos related to

Pageof 28
Sort By:
Rejuvenation Research|March 18, 2008
Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?Cynthia A Lemere, Jiwon Oh, Heather A Stanish, et al.
Journal of Biochemistry|November 6, 2002
Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related proteinMasaaki Narita, David M Holtzman, Anne M Fagan, et al.
Neurology|June 28, 2013
Preclinical Alzheimer disease and risk of fallsSusan L Stark, Catherine M Roe, Elizabeth A Grant, et al.
Journal of Applied Statistics|June 27, 2022
Statistical estimation and comparison of group-specific bivariate correlation coefficients in family-type clustered studiesJingqin Luo, Feng Gao, Jingxia Liu, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's DiseaseAdam P Ingber, Jason Hassenstab, Anne M Fagan, et al.
Psychology and Aging|April 17, 2023
Increased cognitive effort costs in healthy aging and preclinical Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer L Crawford, Jonathan E Peelle, et al.
Neurobiology of Aging|February 25, 2015
Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkersBrian A Gordon, Jeffrey M Zacks, Tyler Blazey, et al.
Archives of Neurology|May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathologyAnne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2020
Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's DiseaseJulie K Wisch, Catherine M Roe, Ganesh M Babulal, et al.
Neuroscience Letters|August 3, 2017
A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and ParkinsonismJohn M Ringman, Maria Casado, Victoria Van Berlo, et al.
Pageof 28

Showing results (61-70 of 279) with videos related to

Sort By:
Pageof 28
Rejuvenation Research|March 18, 2008
Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?Cynthia A Lemere, Jiwon Oh, Heather A Stanish, et al.
Journal of Biochemistry|November 6, 2002
Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related proteinMasaaki Narita, David M Holtzman, Anne M Fagan, et al.
Neurology|June 28, 2013
Preclinical Alzheimer disease and risk of fallsSusan L Stark, Catherine M Roe, Elizabeth A Grant, et al.
Journal of Applied Statistics|June 27, 2022
Statistical estimation and comparison of group-specific bivariate correlation coefficients in family-type clustered studiesJingqin Luo, Feng Gao, Jingxia Liu, et al.
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's DiseaseAdam P Ingber, Jason Hassenstab, Anne M Fagan, et al.
Psychology and Aging|April 17, 2023
Increased cognitive effort costs in healthy aging and preclinical Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer L Crawford, Jonathan E Peelle, et al.
Neurobiology of Aging|February 25, 2015
Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkersBrian A Gordon, Jeffrey M Zacks, Tyler Blazey, et al.
Archives of Neurology|May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathologyAnne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2020
Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's DiseaseJulie K Wisch, Catherine M Roe, Ganesh M Babulal, et al.
Neuroscience Letters|August 3, 2017
A novel PSEN1 (S230N) mutation causing early-onset Alzheimer's Disease associated with prosopagnosia, hoarding, and ParkinsonismJohn M Ringman, Maria Casado, Victoria Van Berlo, et al.
Pageof 28